{"id":238544,"date":"2026-06-07T10:15:27","date_gmt":"2026-06-07T15:15:27","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/06\/engineered-stem-cells-reverse-new-onset-type-1-diabetes-in-mice"},"modified":"2026-06-07T10:15:27","modified_gmt":"2026-06-07T15:15:27","slug":"engineered-stem-cells-reverse-new-onset-type-1-diabetes-in-mice","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/06\/engineered-stem-cells-reverse-new-onset-type-1-diabetes-in-mice","title":{"rendered":"Engineered stem cells reverse new-onset type 1 diabetes in mice"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/engineered-stem-cells-reverse-new-onset-type-1-diabetes-in-mice2.jpg\"><\/a><\/p>\n<p>A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse model of the disease. The work is <a href=\"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626002170\" target=\"_blank\">published<\/a> in the journal Molecular Therapy.<\/p>\n<p>Hongjun Wang, Ph.D., associate director of the South Carolina Clinical &amp; Translational Research (SCTR) Institute Pilot Program and co-scientific director for the Center for Cellular Therapy, led the team. Co-first authors Hua Wei, Ph.D.; Judong Kim, Ph.D.; and Wenyu Gou, Ph.D., together with other collaborators, conducted most of the work to establish these findings.<\/p>\n<p>This research study marks a pivotal move away from the current standard of managing blood sugar through multiple daily insulin injections and toward a lasting way to reprogram the immune system itself. For the millions of people currently living with T1D, this could be a game-changer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse model of the disease. The work is published in the journal Molecular Therapy. Hongjun Wang, Ph.D., associate director of the South [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-238544","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/238544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=238544"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/238544\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=238544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=238544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=238544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}